CL Stock Recent News

NEW YORK--(BUSINESS WIRE)--Colgate-Palmolive (NYSE:CL) Chairman, President and CEO, Noel Wallace, and EVP, General Manager, India, Prabha Narasimhan, will present on Friday, February 21, 2025 at 8:00 am ET at the Consumer Analyst Group of New York Conference. Investors may access a live webcast of this presentation and the presentation slides on Colgate's website at www.colgatepalmolive.com. For those unable to participate during the live webcast, a recorded version of the webcast will be made.

Colgate-Palmolive stock (NYSE: CL) recently reported its Q4 results, with revenues missing and earnings slightly ahead of the street estimates. The company reported revenue of $4.94 billion and adjusted earnings of $0.91 per share, compared to the consensus estimates of $4.99 billion and $0.89, respectively.

Colgate-Palmolive Company CL posted mixed results for the fourth quarter on Friday.

Shares of Colgate-Palmolive (CL -4.61%) pulled back today after the household products giant missed the mark on the top line in its fourth-quarter earnings report and gave a weak outlook.

Goldman Sachs analyst Bonnie Herzog reiterated a Buy rating on the shares of Colgate-Palmolive Co CL with a price forecast of $106.

CL's Q4 results show continued gains from volume and pricing, leading to organic sales growth in five of the six divisions. Improved gross margins aid EPS growth.

Today's pre-market activity is positive, with futures in the green across major indexes: the Dow is +110 points at this hour, with the S&P 500 +26 and the Nasdaq leading the way, +158 points. The small-cap Russell 2000 is +5.

Colgate-Palmolive (CL) shares fell 5% Friday after the household products company missed revenue forecasts and gave weak guidance as it was hurt by foreign exchange rates.

Toothpaste and manual toothbrushes market leader Colgate-Palmolive Company released its fourth quarter and full-year 2024 results today. Judging by the share price reaction, and considering CL stock is down more than 20% from its all-time high, this clearly looks like a “buy the dip” moment. However, I'll explain why I don't think it's a good idea to buy CL shares, either for dividend or total return investors, and despite the company's undoubtedly solid 2024 performance.

Colgate-Palmolive Company (NYSE:CL ) Q4 2024 Earnings Conference Call January 31, 2025 8:30 AM ET Company Participants John Faucher - Chief Investor Relations Officer and Executive Vice President, M&A Noel Wallace - Chairman, President and Chief Executive Officer Stanley Sutula - Chief Financial Officer Conference Call Participants Dara Mohsenian - Morgan Stanley Peter Grom - UBS Bonnie Herzog - Goldman Sachs Andrea Teixeira - JPMorgan Kaumil Gajrawala - Jefferies Kevin Grundy - BNP Bryan Spillane - Bank of America Olivia Tong - Raymond James Sergio Matsumoto - TD Cowen Christopher Carey - Wells Fargo Stephen Powers - Deutsche Bank Lauren Lieberman - Barclays Robert Ottenstein - Evercore ISI Korinne Wolfmeyer - Piper Sandler Mark Astrachan - Stifel Filippo Falorni - Citi Edward Lewis - Redburn Atlantic Operator Good morning. Welcome to today's Colgate-Palmolive 2024 Fourth Quarter and Year End Earnings Conference Call.